GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

XW003 injection

Company
Hangzhou Sciwind Biosciences Co., Ltd.
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for XW003 injection and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07387094

    A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

    Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 140 participants Est. completion 2027-12-16 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07434050

    A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

    Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 140 participants Est. completion 2028-06-19 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04389775

    To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

    Not yet reported Sciwind Biosciences APAC CO Pty. Ltd. 64 participants Est. completion 2021-09-29 1 site Stand-alone
    Type 2 diabetesMASH Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05111912

    Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity

    Not yet reported Sciwind Biosciences APAC CO Pty. Ltd. 206 participants Est. completion 2022-12-20 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05680129

    A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM

    Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 623 participants Est. completion 2024-10-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05680155

    A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

    Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 211 participants Est. completion 2024-10-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05813795

    A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity

    Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 664 participants Est. completion 2024-10-10 1 site Stand-alone
    Other conditions: Weight Management
    View official trial listing →
  • Completed NCT NCT06335134

    A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

    Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 57 participants Est. completion 2024-06-28 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT07073417

    A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)

    Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 163 participants Est. completion 2027-08-23 1 site Stand-alone
    Other conditions: Obesity, Weight Management
    View official trial listing →
  • Completed NCT NCT07143227

    A Study of XW003 Injection in Chinese Adolescents With Obesity

    Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 48 participants Est. completion 2026-04-18 1 site Stand-alone
    Other conditions: Obese Adolescents, Obesity
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: XW003 injection, XW003

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.